Self-Perceptions of Physical Activity in Survivors of Acute Lymphoblastic Leukemia in Childhood

2003 ◽  
Vol 15 (2) ◽  
pp. 191-201 ◽  
Author(s):  
Marilyn J. Wright ◽  
Victoria Galea ◽  
Ronald D. Barr

Participation in physical activity has important beneficial effects on physical and psychological health. Many outcomes associated with physical activity are typically compromised in survivors of childhood cancer. The purpose of this study was to describe self-perceptions of physical activity in survivors of acute lymphoblastic leukemia (ALL) and to explore the relationships of these findings with quality of life measures and clinical descriptors. 62 children and adolescents treated previously for ALL and 71 comparable healthy subjects completed the Children’s Self-perceptions of Adequacy in and Predilection for Physical Activity (CSAPPA) scale and the Health Utilities Index (HUI). The ALL subjects had significantly poorer self-perceptions of their adequacy in and predilection for physical activity than the comparison group. Stepwise regression analyses identified high risk for relapse, female gender, and older age, but not body-mass-index, age, age at diagnosis, length of time off therapy, or cranial irradiation as significant predictors of CSAPPA total scores in the ALL group. HUI overall scores and single attribute scores for emotion, cognition and pain had significant positive correlations with various CSAPPA scores. Results suggest that survivors of ALL are less inclined to participate in physical activity and physical activity scores are related to quality of life scores. Long-term follow-up should include education and programming to promote participation in physical activity.

2021 ◽  
pp. 1-11
Author(s):  
Stephane Lepretre ◽  
Chantal Touboul ◽  
Alain Flinois ◽  
Lucie Kutikova ◽  
Christina Giannopoulou ◽  
...  

2020 ◽  
Vol 28 (1) ◽  
pp. 252-259
Author(s):  
Warren Fingrut ◽  
Wendy Davis ◽  
Eric McGinnis ◽  
Karen Dallas ◽  
Khaled Ramadan ◽  
...  

Salvage options for patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) include inotuzumab ozogamicin (InO), a recombinant, humanized anti-CD22 monoclonal antibody conjugated to the cytotoxic antibiotic calicheamicin. However, the benefit of InO in patients with dim CD22 expression remains unclear. We present a case of a patient with B-ALL who responded to InO despite only dim surface expression of CD22 by flow cytometry, achieving a survival benefit concordant with that reported in the literature and maintaining a good quality of life as a transfusion-independent outpatient. Our observation has broad relevance to clinicians who manage patients with B-ALL who are candidates for InO.


2012 ◽  
Vol 34 (7) ◽  
pp. 517-523 ◽  
Author(s):  
Catherine Maude Pound ◽  
Camillia Clark ◽  
Andy Ni ◽  
Uma Athale ◽  
Victor Lewis ◽  
...  

Blood ◽  
2018 ◽  
Vol 131 (26) ◽  
pp. 2906-2914 ◽  
Author(s):  
Max S. Topp ◽  
Zachary Zimmerman ◽  
Paul Cannell ◽  
Hervé Dombret ◽  
Johan Maertens ◽  
...  

Key Points Blinatumomab delays deterioration in HRQL in adults with R/R ALL.


2013 ◽  
Vol 7 (3) ◽  
pp. 404-412 ◽  
Author(s):  
Mirja Erika Gunn ◽  
Päivi Maria Lähteenmäki ◽  
Leena-Riitta Puukko-Viertomies ◽  
Markus Henriksson ◽  
Risto Heikkinen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document